Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""United States Food and Drug Administration"" wg kryterium: Temat


Tytuł :
Statins No Longer Contraindicated in Pregnancy.
Autorzy :
Aschenbrenner DS; Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch: .
Pokaż więcej
Źródło :
The American journal of nursing [Am J Nurs] 2021 Nov 01; Vol. 121 (11), pp. 22.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Approval*
United States Food and Drug Administration*
Atorvastatin/*therapeutic use
Cardiovascular Diseases/*drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Pravastatin/*therapeutic use
Contraindications ; Female ; Humans ; Pregnancy ; United States
Czasopismo naukowe
Tytuł :
The U.S. Food and Drug Administration's role in improving radiation dose management for medical X-ray imaging devices.
Autorzy :
Miller DL; Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring, MD, USA.
Kakar S; Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring, MD, USA.
Jiang L; Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring, MD, USA.
Spelic DC; Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring, MD, USA.
Burk L; Center for Devices and Radiological Health U.S. Food and Drug Administration Silver Spring, MD, USA.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Oct 01; Vol. 94 (1126), pp. 20210373. Date of Electronic Publication: 2021 May 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Radiation Dosage*
United States Food and Drug Administration*
Diagnostic Imaging/*instrumentation
Diagnostic Imaging/*standards
Equipment Safety/*standards
Radiation Protection/*standards
Device Approval/legislation & jurisprudence ; Device Approval/standards ; Humans ; Radiation Protection/legislation & jurisprudence ; United States ; X-Rays
Czasopismo naukowe
Tytuł :
Safety profile of chloroquine and hydroxychloroquine: a disproportionality analysis of the FDA Adverse Event Reporting System database.
Autorzy :
Papazisis G; Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. .
Siafis S
Cepatyte D
Giannis D
Stamoula E
Tzachanis D
Egberts T
Pokaż więcej
Źródło :
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Oct; Vol. 25 (19), pp. 6003-6012.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Adverse Drug Reaction Reporting Systems*
United States Food and Drug Administration*
Chloroquine/*adverse effects
Hydroxychloroquine/*adverse effects
COVID-19/drug therapy ; Confidence Intervals ; Databases, Factual ; Humans ; Male ; Middle Aged ; Odds Ratio ; Pharmacovigilance ; Suicide ; United States
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development Speed.
Autorzy :
Pregelj L; School of Chemistry and Molecular Biosciences, University of Queensland Business School, The University of Queensland, St Lucia, Queensland, Australia.
Hine DC; Kemmy Business School, University of Limerick, Limerick, Ireland.
Kesselheim AS; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Darrow JJ; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Law and Taxation, Bentley University, Waltham, Massachusetts, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Oct; Vol. 110 (4), pp. 1018-1024. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Clinical Trials as Topic*
Drug Approval*
Drug Development*
United States Food and Drug Administration*
Drug and Narcotic Control ; Humans ; Time Factors ; United States
Czasopismo naukowe
Tytuł :
Controversial Approval of New Drug to Treat Alzheimer's Disease.
Autorzy :
Aschenbrenner DS; Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch: .
Pokaż więcej
Źródło :
The American journal of nursing [Am J Nurs] 2021 Oct 01; Vol. 121 (10), pp. 22-23.
Typ publikacji :
Journal Article
MeSH Terms :
Randomized Controlled Trials as Topic*
Alzheimer Disease/*drug therapy
Antibodies, Monoclonal, Humanized/*therapeutic use
Drug Approval/*organization & administration
United States Food and Drug Administration/*standards
Administration, Intravenous ; Humans ; Magnetic Resonance Imaging ; Plaque, Amyloid/physiopathology ; Positron-Emission Tomography ; United States ; United States Food and Drug Administration/organization & administration
Czasopismo naukowe
Tytuł :
Heterogeneity in treatment effects across diverse populations.
Autorzy :
Nugent BM; Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Madabushi R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Buch B; Center for Biologics Evaluation & Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Peiris V; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Crentsil V; Office of Drug Evaluation III, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Miller VM; Departments of Surgery, and Physiology and Bioengineering, Mayo Clinic, Rochester, Minnesota, USA.
Bull J; Global Product Development, PPDi, Wilmington, North Carolina, USA.
R Jenkins M; Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło :
Pharmaceutical statistics [Pharm Stat] 2021 Sep; Vol. 20 (5), pp. 929-938. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
United States Food and Drug Administration*
Humans ; United States
Czasopismo naukowe
Tytuł :
Is the FDA Failing Women?
Autorzy :
Kinard M; Founder and chief executive officer of Device EventsTM.
Redberg RF; Cardiologist and professor of medicine at the University of California, San Francisco School of Medicine.
Pokaż więcej
Źródło :
AMA journal of ethics [AMA J Ethics] 2021 Sep 01; Vol. 23 (9), pp. E750-756. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :
Journal Article
MeSH Terms :
United States Food and Drug Administration*
Female ; Humans ; Male ; United States
Czasopismo naukowe
Tytuł :
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
Autorzy :
Sahre MD; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Milligan L; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Madabushi R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Graham RA; Theravance Biopharma US, Inc., South San Francisco, California, USA.
Reynolds KS; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Terzic A; Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Benjamin J; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Burckart GJ; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Huang SM; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Schuck R; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Thompson AM; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Zineh I; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 285-288. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
Advisory Committees/*organization & administration
Clinical Trials as Topic/*organization & administration
Kidney Diseases/*metabolism
Pharmacology, Clinical/*organization & administration
United States Food and Drug Administration/*organization & administration
Advisory Committees/standards ; Area Under Curve ; Clinical Trials as Topic/standards ; Drug Dosage Calculations ; Half-Life ; Kidney Diseases/epidemiology ; Multiple Chronic Conditions/epidemiology ; Pharmacology, Clinical/standards ; United States ; United States Food and Drug Administration/standards
Czasopismo naukowe
Tytuł :
A contentious FDA ruling for Alzheimer's disease.
Autorzy :
The Lancet Neurology
Pokaż więcej
Źródło :
The Lancet. Neurology [Lancet Neurol] 2021 Aug; Vol. 20 (8), pp. 585. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Editorial
MeSH Terms :
Drug Approval*
United States Food and Drug Administration*
Alzheimer Disease/*drug therapy
Antibodies, Monoclonal/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Amyloid/drug effects ; Humans ; United States
Opinia redakcyjna
Tytuł :
An introduction to risk evaluation and mitigation strategies.
Autorzy :
Dohm J; Covington & Burling LLP, DC, United States.
Ji M; Covington & Burling LLP, DC, United States. Electronic address: .
Pokaż więcej
Źródło :
Contraception [Contraception] 2021 Jul; Vol. 104 (1), pp. 4-7. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Approval*
Risk Evaluation and Mitigation*
United States Food and Drug Administration*
Abortifacient Agents, Steroidal ; Drug and Narcotic Control ; Humans ; Mifepristone ; United States
Czasopismo naukowe
Tytuł :
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Autorzy :
Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Fuller CC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Adimadhyam S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Ball R; US Food and Drug Administration, Silver Spring, Maryland, USA.
Brown JS; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Dal Pan GJ; US Food and Drug Administration, Silver Spring, Maryland, USA.
Kluberg SA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Lo Re V 3rd; Division of Infectious Diseases, Department of Medicine, and Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Nguyen M; US Food and Drug Administration, Silver Spring, Maryland, USA.
Orr R; US Food and Drug Administration, Silver Spring, Maryland, USA.
Paraoan D; US Food and Drug Administration, Silver Spring, Maryland, USA.
Perlin J; HCA Healthcare, Nashville, Tennessee, USA.
Poland RE; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA.
Driscoll MR; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Sands K; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.; HCA Healthcare, Nashville, Tennessee, USA.
Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Yih WK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Platt R; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Pokaż więcej
Corporate Authors :
And the FDA-Sentinel COVID-19 Working Group
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Jul; Vol. 30 (7), pp. 827-837. Date of Electronic Publication: 2021 Apr 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
COVID-19/*therapy
Health Information Management/*organization & administration
Product Surveillance, Postmarketing/*methods
Public Health Surveillance/*methods
United States Food and Drug Administration/*organization & administration
Antiviral Agents/therapeutic use ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/adverse effects ; Communicable Disease Control/legislation & jurisprudence ; Databases, Factual/statistics & numerical data ; Electronic Health Records/statistics & numerical data ; Health Policy ; Humans ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; United States/epidemiology ; United States Food and Drug Administration/legislation & jurisprudence
Czasopismo naukowe
Tytuł :
Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.
Autorzy :
Wesley BD; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD. Electronic address: .
Sewell CA; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Chang CY; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Hatfield KP; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Nguyen CP; Division of Urology, Obstetrics & Gynecology, US Food and Drug Administration, Silver Spring, MD.
Pokaż więcej
Źródło :
American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Jul; Vol. 225 (1), pp. 21-32.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Approval*/legislation & jurisprudence
Drug Approval*/statistics & numerical data
Pregnancy*
Prescription Drugs*
United States Food and Drug Administration*
Animals ; Clinical Trials as Topic ; Female ; Fetus/drug effects ; Humans ; Lactation ; Pregnancy Complications/drug therapy ; Risk Assessment ; Teratogens ; United States
Czasopismo naukowe
Tytuł :
Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic.
Autorzy :
Maxwell K
Pokaż więcej
Źródło :
American journal of law & medicine [Am J Law Med] 2021 Jul; Vol. 47 (2-3), pp. 291-326.
Typ publikacji :
Journal Article
MeSH Terms :
Government Regulation*
United States Food and Drug Administration*
Device Approval/*legislation & jurisprudence
Medical Device Legislation/*standards
COVID-19/prevention & control ; Humans ; United States
Czasopismo naukowe
Tytuł :
[Analysis on Work Idea of Medical Device Classification Dynamic Adjustment Mechanism in the United States].
Autorzy :
Zhang C; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Zhou L; Guangdong Medical Devices Quality Surveillance and Test Institute, Guangzhou, 510663.
Wang Y; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Tian L; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Yu X; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Ji X; National Center of Standards Evaluation, SAMR, Beijing, 100088. E-mail:.
Zhang H; NationalInstitutes for Food and Drug Control, Beijing, 100050.
Pokaż więcej
Źródło :
Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2021 Jun 08; Vol. 45 (3), pp. 315-320.
Typ publikacji :
Journal Article
MeSH Terms :
United States Food and Drug Administration*
China ; United States
Czasopismo naukowe
Tytuł :
Adverse events involving hallux metatarsophalangeal joint implants: Analysis of the United States Food and Drug Administration data from 2010 to 2018.
Autorzy :
Akoh CC; Duke University Medical Center, Box 2887, Durham, NC 27710, United States. Electronic address: .
Chen J; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Kadakia R; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Park YU; Department of Orthopedic Surgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Gyeonggido, Republic of Korea.
Kim H; Department of Orthopedic Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Adams SB; Duke University Medical Center, Box 2887, Durham, NC 27710, United States.
Pokaż więcej
Źródło :
Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons [Foot Ankle Surg] 2021 Jun; Vol. 27 (4), pp. 381-388. Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
Databases, Factual*
United States Food and Drug Administration*
Arthrodesis/*instrumentation
Arthroplasty, Replacement/*instrumentation
Hallux/*surgery
Hallux Rigidus/*surgery
Joint Prosthesis/*adverse effects
Metatarsophalangeal Joint/*surgery
Osteoarthritis/*surgery
Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Osteoarthritis/epidemiology ; Prosthesis Failure/etiology ; Prosthesis-Related Infections/etiology ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies